To establish whether there was any difference in disease stage in patients with screening-detected colorectal cancer (CRC) in a Caribbean country.
Cardiovascular disease (CVD) is the leading cause of death in the Americas, and high blood pressure accounts for over 50% of CVD. Unfortunately, in the Americas, over a quarter of adult women and four in ten adult men have hypertension, and the diagnosis, treatment, and control are suboptimal. Remarkably, only a few countries exhibit a population hypertension control rate of over 50%.
To describe the relation between corruption indicators and statistics on noncommunicable diseases and their risk factors by continent.
An ecological study was conducted to examine the relation of the GINI coefficient, the Country Policy and Institutional Assessment (CPIA), and the Corruption Perception Index (CPI) with noncommunicable diseases, using the Spearman’s rank correlation test.
To evaluate molecular tools to detect low-level parasitemia and the five species of Plasmodium that infect humans for use in control and elimination programs, and in reference laboratories.
HEARTS in the Americas is the regional adaptation of the World Health Organization’s Global Hearts Initiative, which will be the model for risk management for cardiovascular disease (CVD) in primary health care in the Region of the Americas by 2025. It has already been implemented in 21 countries and 1045 primary health care centers throughout Latin America and the Caribbean. It takes a public health and health systems approach to systematically introduce simplified interventions at the primary health care level and focuses on hypertension as a clinical entry point.
Study the feasibility of using artificial intelligence as a sensitive and specific method for COVID-19 screening in patients with respiratory conditions, using chest CT scan images and a telemedicine platform.
This paper presents a method to estimate excess mortality where national data are missing for some or all of the coronavirus disease 2019 (COVID-19) pandemic period, but subnational data exist, such as in Argentina. By making use of the stability of the regional distribution of deaths, data on deaths in Córdoba province were used to project excess deaths in Argentina from March 2020 up to the end of 2021. The number of excess deaths was estimated at 134 504, which is 14.8% higher than the reported number of COVID-19 deaths in Argentina for the same time period.
Identify publications from 2000 to 2020 on hepatitis B in indigenous people in Latin America, to learn about advances and gaps in this field in the last 20 years.
Exploratory review and systematic evidence review. Documents were organized using Excel and Rayyan® software.
In the face of the coronavirus disease 2019 (COVID-19) pandemic, the entire world is concerned with achieving desired herd immunity to overcome the current health crisis. Estimating the efficacy that could be attained in a population by combining vaccines of different brands or technologies would be a valuable asset for public health decision-makers in the present pandemic and in similar future scenarios. This article provides a mathematical formula to estimate probable efficacy against COVID-19 when administering two vaccines in a specific population.
To describe the epidemiological behavior of leprosy in several Latin American countries during 2011-2020, based on World Health Organization (WHO) indicators.
